Citation

Lainchbury M, Matthews TP, McHardy T, Boxall KJ, Walton MI, Eve PD, Hayes A, Valenti MR, de Haven Brandon AK, Box G, Aherne GW, Reader JC, Raynaud FI, Eccles SA, Garrett MD, Collins I.: Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. J Med Chem, Volume 55 (22), 2012

Authors

Aherne GW, Box G, Boxall KJ, Collins I., de Haven Brandon AK, Eccles SA, Eve PD, Garrett MD, Hayes A, Lainchbury M, Matthews TP, McHardy T, Raynaud FI, Reader JC, Valenti MR, Walton MI

Journal

J Med Chem

Year

2012

DOI

10.1021/jm3012933

PubMed

23082860

Machine-readable

REST APIRDF